Bioconjugation services

Our services range from early development to the manufacture of an investigational medicinal product (IMP) / drug substance for first clinical trials in human. Service modules can be selected individually or as the whole package according to the customer’s needs. Bioconjugation services are accompanied by analytics that are individually adjusted to the needs of the bioconjugate.

Pipette Holder

Feasibility studies

Process development


Contact partner

Dr. Julia Wittmann

Dr. Julia Wittmann
Head of Bioconjugation

+49 30  9489 2350

Call us

+49 (0) 30 94892350

Write to us